{"id":"NCT00091442","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","briefTitle":"A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer","officialTitle":"A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-09","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2004-09-13","resultsPosted":"2012-10-02","lastUpdate":"2014-04-21"},"enrollment":751,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Docetaxel","otherNames":[]},{"type":"DRUG","name":"DOXIL","otherNames":["DOXIL in combination with Docataxel"]}],"arms":[{"label":"DOXIL and docetaxel combination therapy","type":"EXPERIMENTAL"},{"label":"Docetaxel monotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to evaluate whether the time to progression for the DOXIL and docetaxel combination therapy group was superior to that of the group treated with docetaxel monotherapy in participants with advanced breast cancer.","primaryOutcome":{"measure":"Time to Progression","timeFrame":"From date of randomization until date of disease progression or death, whichever occurred first, until approximately 485 events of disease progression or death were observed, as assessed approximately 15 months after the last patient was enrolled","effectByArm":[{"arm":"Docetaxel","deltaMin":7,"sd":null},{"arm":"DOXIL+Docetaxel","deltaMin":9.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":147,"countries":["United States","Bulgaria","Estonia","France","Hungary","Israel","Latvia","Lithuania","Netherlands","Poland","Portugal","Romania","Russia","Serbia","South Africa","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":373},"commonTop":["Neutropenia","Alopecia","Mucositis/stomatitis","Palmar-plantar erythrodysaesthesia syndrome","Leukopenia"]}}